V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10007411 | 10005278 | 1.76 | null | Adjuvant (A) | 2018-02-15 | 2018-02-13 | Cisplatin + Radiotherapy | 02 | N | 10545602 | VINORELBINE |
| 10007412 | 10005280 | 1.83 | 90 | Neo-adjuvant (N) | 2015-07-06 | 2015-08-02 | CHOP | N | N | 10545673 | AML18 TRIAL |
| 10007413 | 10005282 | 1.64 | 58 | Curative (C) | 2015-09-04 | 2015-09-11 | Bortezomib + Panobinostat | 02 | N | 10545700 | VINORELBINE |
| 10007414 | 10007628 | 1.74 | 83.9 | Palliative (P) | 2018-12-24 | 2019-03-03 | Irinotecan 14day | 02 | N | 10545781 | CHOP |
| 10007415 | 10007628 | 1.7 | 108 | Palliative (P) | null | 2015-09-22 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | N | N | 10545781 | BRENTUXIMAB |
| 10007416 | 10005285 | 1.6 | 56 | Adjuvant (A) | 2017-11-18 | 2017-11-25 | ENRICH Trial | 2 | N | 10545782 | FLUOROURACIL + MITOMYCIN + RT |
| 10007417 | 10005286 | 1.77 | 65.8 | Adjuvant (A) | 2017-09-06 | 2017-09-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 10545971 | GDP |
| 10007418 | 10005286 | 1.7 | 53 | Palliative (P) | 2017-09-24 | 2017-09-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | 10545971 | FEC + DOCETAXEL |
| 10007419 | 10005289 | 1.71 | 56.4 | Palliative (P) | 2018-06-03 | 2018-06-04 | CETUXIMAB + IRINOTECAN | N | N | 10546212 | TEMOZOLOMIDE + RT |
| 10007420 | 10005290 | 1.65 | 61 | Curative (C) | 2018-04-10 | 2018-04-10 | Cisplatin | 01 | N | 10546246 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 10007421 | 10005291 | 1.7 | 60.4 | Adjuvant (A) | 2017-09-11 | 2017-09-11 | Carboplatin + Liposomal Doxorubicin | 02 | N | 10546260 | CABOZANTINIB |
| 10007422 | 10007631 | 1.81 | null | Palliative (P) | 2014-11-07 | 2014-11-16 | CAV | 02 | N | 10546378 | CISPLATIN + PEMETREXED |
| 10007423 | 10005293 | 1.72 | 85 | Curative (C) | 2017-09-23 | 2017-10-08 | ESHAP | N | N | 10546381 | MPV |
| 10007424 | 10005294 | 1.73 | 77.4 | Disease modification (D) | 2018-11-29 | 2018-12-08 | Irinotecan 14day | 02 | N | 10546510 | CAPECITABINE + GEMCITABINE |
| 10007425 | 10005295 | 1.84 | 93.7 | Curative (C) | 2017-01-13 | 2017-01-24 | Bortezomib +/- Dexamethasone | N | N | 10546526 | VEMURAFENIB |
| 10007426 | 10005295 | 1.71 | 73 | Palliative (P) | 2018-06-13 | 2018-06-13 | Cape+Cisplatin+Trastuzumab Load | 02 | N | 10546526 | ERLOTINIB |
| 10007427 | 10005298 | 1.76 | null | Curative (C) | 2017-07-23 | 2017-08-08 | VEPEMB | null | null | 10546671 | CHLORAMBUCIL |
| 10007428 | 10005299 | 1.78 | 66.4 | Palliative (P) | 2015-05-24 | 2015-08-20 | Mini BEAM | 02 | Y | 10546689 | CISPLATIN + RT |
| 10007429 | 10005300 | 1.81 | 0 | Disease modification (D) | 2014-05-08 | 2014-05-09 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 10546808 | METHOTREXATE INTRATHECAL |
| 10007430 | 10005303 | 1.71 | null | Palliative (P) | 2017-02-26 | 2018-03-01 | Capecitabine + Mitomycin | N | null | 10547111 | CARBOPLATIN + LIPOSOMAL DOX |
| 10007431 | 10005305 | 1.88 | 77.4 | null | 2018-01-11 | 2018-01-11 | Arsenic trioxide + Tretinoin | 2 | N | 10547331 | IRINOTECAN |
| 10007432 | 10007638 | 1.75 | null | null | 2015-03-10 | 2015-03-14 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | N | null | 10547404 | CISPLATIN + PEMETREXED |
| 10007433 | 10005306 | 1.57 | 52 | Palliative (P) | 2018-09-12 | 2018-09-12 | FEC | 2 | N | 10547673 | FEC |
| 10007434 | 10005307 | 0 | 53 | Palliative (P) | 2017-02-26 | 2017-02-27 | MA (Cytarabine 3g/m2) | N | Y | 10547784 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 10007435 | 10005308 | 1.75 | 91 | Curative (C) | 2017-06-30 | 2017-07-02 | IPILIMUMAB + NIVOLUMAB | N | N | 10547784 | BORTEZOMIB |
| 10007436 | 10005309 | 1.66 | 56.4 | Palliative (P) | 2017-06-16 | 2017-06-26 | RUXOLITINIB | 02 | Y | 10547858 | IRINOTECAN |
| 10007437 | 10005309 | null | 56 | Palliative (P) | 2016-12-05 | 2016-12-06 | Oxaliplatin + Raltitrexed | 2 | Y | 10547858 | EOX |
| 10007438 | 10005310 | 1.72 | 83.1 | Disease modification (D) | 2017-01-15 | 2017-01-15 | Pazopanib | 2 | N | 10548165 | DOXORUBICIN + OLARATUMAB |
| 10007439 | 10005311 | 1.57 | 64.6 | Palliative (P) | 2016-05-04 | 2016-05-04 | CYCLOPHOSPHAMIDE + EPIRUBICIN | N | N | 10548238 | CARBOPLATIN + DOXORUBICIN |
| 10007440 | 10005312 | 1.76 | 85.5 | Curative (C) | 2017-01-04 | 2017-01-04 | ECX | N | N | 10548566 | RALTITREXED |
| 10007441 | 10005313 | 1.78 | null | Palliative (P) | 2017-09-07 | 2017-09-11 | Cetuximab 14 day | N | null | 10548703 | CETUXIMAB |
| 10007442 | 10007641 | 1.52 | 71 | Curative (C) | 2018-09-19 | 2018-09-26 | PERTUZUMAB + TRASTUZUMAB | Y | N | 10548704 | DABRAFENIB + TRAMETINIB |
| 10007443 | 10007641 | 1.65 | 134 | Disease modification (D) | 2015-04-22 | 2015-04-26 | GEMTUZUMAB OZOGAMICIN | N | N | 10548704 | ENZALUTAMIDE |
| 10007444 | 10005315 | 1.88 | 60 | Palliative (P) | 2017-10-17 | 2017-10-23 | BENDAMUSTINE | N | N | 10548822 | EVEROLIMUS |
| 10007445 | 10005315 | 1.72 | null | Neo-adjuvant (N) | 2016-10-24 | 2016-10-31 | Lomustine | N | N | 10548822 | LIPOSOMAL DOXORUBICIN |
| 10007446 | 10005316 | 1.77 | 96 | Palliative (P) | 2018-12-15 | 2019-01-12 | GDP | 2 | N | 10548972 | TOPOTECAN |
| 10007447 | 10005317 | null | null | Disease modification (D) | 2017-09-12 | 2017-09-18 | IMATINIB | N | N | 10548978 | IMATINIB |
| 10007448 | 10005318 | 1.75 | 84.9 | Curative (C) | null | 2014-05-11 | CAPECITABINE + IRINOTECAN | n | N | 10548978 | CAPECITABINE + GEMCITABINE |
| 10007449 | 10005320 | null | 75.8 | Curative (C) | 2017-08-12 | 2017-09-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 10549121 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 10007450 | 10005321 | 1.87 | 61.9 | null | 2018-09-15 | 2018-09-15 | CABOZANTINIB | 02 | null | 10549181 | R CODOX M |
| 10007451 | 10008640 | 1.74 | 93 | Palliative (P) | 2016-11-29 | 2016-12-19 | CETUXIMAB | 02 | N | 10549203 | ECX |
| 10007452 | 10005322 | 1.77 | 78 | Palliative (P) | 2017-03-08 | 2017-04-20 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 2 | N | 10549263 | LEAM |
| 10007453 | 10005323 | 1.72 | 86.4 | Palliative (P) | 2017-06-07 | 2017-06-13 | Chlorambucil | 2 | N | 10549295 | BORTEZOMIB |
| 10007454 | 10005324 | null | 101.9 | Radical (R) | 2018-12-26 | 2018-12-27 | POMALIDOMIDE | 02 | N | 10549592 | CISPLATIN + GEMCITABINE |
| 10007455 | 10005324 | 1.73 | 75.3 | Palliative (P) | 2014-06-27 | 2014-07-07 | RUXOLITINIB | N | N | 10549592 | MITOXANTRONE |
| 10007456 | 10005325 | 1.59 | 71 | Palliative (P) | 2014-09-19 | 2014-09-20 | Bortezomib + CYCLOPHOSPHAMIDE | N | Y | 10549795 | CISPLATIN + FLUOROURACIL |
| 10007457 | 10005325 | 1.55 | 81 | Palliative (P) | 2018-08-06 | 2018-09-07 | Bortezomib +/- Dexamethasone | 2 | N | 10549795 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 10007458 | 10005328 | 0 | 74.3 | null | 2017-09-15 | 2017-10-17 | Capecitabine + Cisplatin + RT | null | N | 10550086 | ABVD |
| 10007459 | 10007648 | 1.68 | 65 | Disease modification (D) | 2018-01-24 | 2018-06-14 | ECX | 02 | N | 10550104 | CHLVPP |
| 10007460 | 10007649 | 1.54 | 73 | Palliative (P) | 2018-05-09 | 2018-07-21 | Carboplatin + Liposomal Doxorubicin | N | N | 10550149 | CYCLOPHOSPHAMIDE |